Results 261 to 270 of about 861,614 (343)
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
British Journal of Clinical Pharmacology, EarlyView.Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
A qualitative study on the experience of stigma of family caregivers of children with autism from the perspective of family empowerment. [PDF]
BMC NursLi B, Le J, Wang Y.
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
The mental health of informal caregivers in Ontario: an epidemiological survey.
, 1997 Jean-Philippe Cochrane +2 more
openalex +2 more sources
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer
British Journal of Clinical Pharmacology, EarlyView.Aims Treatment with enzalutamide in prostate cancer is challenging due to its high potential for drug–drug interactions, particularly in the typically older population of patients with frequent comorbidities treated with multiple drugs, such as anticoagulants.
Catharina J. P. Op 't Hoog +8 more
wiley +1 more source
Gender Difference in the Caregiving Burden and Psychological Distress of Family Caregivers of Liver Transplant Recipients. [PDF]
Nurs OpenLiao CH, Lee WC, Wang YW, Weng LC.
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
Factors Influencing Long-term Home Care for Patients with Tracheostomy from the Perspectives of their Family Members. [PDF]
Iran J Nurs Midwifery ResBabanataj R, Alavi NM, Shoja M.
europepmc +1 more source